Disposition of 175 shares by Allyson Guidroz of Amedisys at 91.15 subject to Rule 16b-3
AMED Stock | USD 92.41 0.13 0.14% |
About 56% of Amedisys' investor base is looking to short. The analysis of the overall prospects from investing in Amedisys suggests that many traders are, at the present time, alarmed. The current market sentiment, together with Amedisys' historical and current headlines, can help investors time the market. In addition, many technical investors use Amedisys stock news signals to limit their universe of possible portfolio assets.
Amedisys |
Filed transaction by Amedisys Officer Chief Accounting Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Amedisys Fundamental Analysis
We analyze Amedisys' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amedisys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amedisys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Amedisys is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Amedisys Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amedisys stock to make a market-neutral strategy. Peer analysis of Amedisys could also be used in its relative valuation, which is a method of valuing Amedisys by comparing valuation metrics with similar companies.
Peers
Amedisys Related Equities
SGRY | Surgery Partners | 21.18 | ||||
INNV | InnovAge Holding | 5.90 | ||||
EHAB | Enhabit | 3.69 | ||||
ACHC | Acadia Healthcare | 3.11 | ||||
EHC | Encompass Health | 2.97 | ||||
ENSG | Ensign | 1.58 | ||||
OPCH | Option Care | 1.45 | ||||
UHS | Universal Health | 1.13 | ||||
NHC | National HealthCare | 1.09 | ||||
PNTG | Pennant | 0.11 | ||||
ADUS | Addus HomeCare | 0.34 | ||||
HCSG | Healthcare Services | 1.50 |
Complementary Tools for Amedisys Stock analysis
When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |